Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative
US5571800A · kind A · utility
5Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 1994 |
| Grant date | Nov 5, 1996 |
| Priority date | — |
| Expiry date | Feb 14, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/706
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for suppressing the rejection of an allograft comprising administering azaribine at a time when the recipient of the allograft begins to mount a reject reaction against the allograft.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.